These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37848035)

  • 1. Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.
    Boxer AL; Sperling R
    Cell; 2023 Oct; 186(22):4757-4772. PubMed ID: 37848035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
    Piazza F; Winblad B
    J Alzheimers Dis; 2016 Mar; 52(2):417-20. PubMed ID: 27031492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?
    Korologou-Linden R; Kalsi J; Kafetsouli D; Olawale A; Iwata A; Wingfield D; Mummery D; Hayhoe B; Robinson O; Majeed A; Middleton LT
    J Prev Alzheimers Dis; 2024; 11(4):897-902. PubMed ID: 39044500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report.
    Delrieu J; Bateman RJ; Touchon J; Sabbagh M; Cummings J
    J Prev Alzheimers Dis; 2022; 9(3):393-399. PubMed ID: 35841240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review.
    Chowdhury S; Chowdhury NS
    Int J Immunopathol Pharmacol; 2023; 37():3946320231209839. PubMed ID: 37902139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease.
    Avgerinos KI; Ferrucci L; Kapogiannis D
    Ageing Res Rev; 2021 Jul; 68():101339. PubMed ID: 33831607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future of Anti-Amyloid Trials.
    Aisen PS; Cummings J; Doody R; Kramer L; Salloway S; Selkoe DJ; Sims J; Sperling RA; Vellas B
    J Prev Alzheimers Dis; 2020; 7(3):146-151. PubMed ID: 32463066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model).
    Mazer NA; Hofmann C; Lott D; Gieschke R; Klein G; Boess F; Grimm HP; Kerchner GA; Baudler-Klein M; Smith J; Doody RS;
    Alzheimers Dement; 2023 Jun; 19(6):2287-2297. PubMed ID: 36454709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on pharmacological treatment for Alzheimer's disease.
    Tipton PW
    Neurol Neurochir Pol; 2024; 58(2):150-160. PubMed ID: 37606550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
    Digma LA; Winer JR; Greicius MD
    J Alzheimers Dis; 2024; 97(2):567-572. PubMed ID: 38250779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
    Swanson CJ; Zhang Y; Dhadda S; Wang J; Kaplow J; Lai RYK; Lannfelt L; Bradley H; Rabe M; Koyama A; Reyderman L; Berry DA; Berry S; Gordon R; Kramer LD; Cummings JL
    Alzheimers Res Ther; 2021 Apr; 13(1):80. PubMed ID: 33865446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
    Rafii MS; Sperling RA; Donohue MC; Zhou J; Roberts C; Irizarry MC; Dhadda S; Sethuraman G; Kramer LD; Swanson CJ; Li D; Krause S; Rissman RA; Walter S; Raman R; Johnson KA; Aisen PS
    Alzheimers Dement; 2023 Apr; 19(4):1227-1233. PubMed ID: 35971310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
    Volloch V; Rits-Volloch S
    J Alzheimers Dis; 2023; 93(4):1277-1284. PubMed ID: 37212119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donanemab: Not two without a third.
    Kurkinen M
    Adv Clin Exp Med; 2023 Oct; 32(10):1085-1087. PubMed ID: 37831471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once upon a time, the Amyloid Cascade Hypothesis.
    Granzotto A; Sensi SL
    Ageing Res Rev; 2024 Jan; 93():102161. PubMed ID: 38065226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies.
    Imbimbo BP; Ippati S; Watling M; Imbimbo C
    Pharmacol Res; 2023 Jan; 187():106631. PubMed ID: 36586644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What works and what does not work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials.
    Bullain S; Doody R
    J Neurochem; 2020 Sep; 155(2):120-136. PubMed ID: 32277473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns.
    Lu D; Dou F; Gao J
    Drug Discov Ther; 2023; 17(6):440-444. PubMed ID: 38220210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.